Display Settings:

Format

Send to:

Choose Destination
    Health Aff (Millwood). 2009 Nov-Dec;28(6):1629-41.

    Investing to meet the scientific challenges of HIV/AIDS.

    Source

    National Institute ofAllergy and Infectious Diseases at National Institutes of Health in Bethesda, Maryland, USA.

    Abstract

    Despite extraordinary scientific advances over more than twenty-five years, the human immunodeficiency virus (HIV) continues to exact an enormous toll worldwide. Given the limitations of current HIV treatment and prevention interventions and the financial and logistical impediments to delivering them, new and potentially transforming interventions are needed if the HIV/AIDS pandemic is to be significantly slowed. Serious scientific challenges remain in the realm of developing potentially curative therapies and a safe and effective HIV vaccine, and in developing, assessing, and validating other new prevention modalities. Substantial funding of the research enterprise must be maintained.

    PMID:
    19887404
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk